Search results
BioNTech SE (NASDAQ:BNTX) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
Simply Wall St. via Yahoo Finance· 2 days agoInvestors in BioNTech SE (NASDAQ:BNTX) had a good week, as its shares rose 2.3% to close at US$90.88...
BioNTech Se (BNTX) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 4 days agoImage source: The Motley Fool. BioNTech Se (NASDAQ: BNTX) Q1 2024 Earnings Call May 06, 2024, 8:00 a.m. ET Contents: Prepared Remarks Questions and...
Earnings call: BioNTech targets oncology growth, plans new COVID vaccine By Investing.com
Investing.com· 3 days agoBioNTech SE (NASDAQ:BNTX), a biotechnology company, reported its first-quarter financial results for...
What's Going With BioNTech Stock On Monday?
Benzinga· 4 days agoMonday, BioNTech SE BNTX reported a first-quarter EPS loss of 1.31 euros ($1.41 loss), a shift from an income of 2.05 euros, missing the consensus loss...
BioNTech Lifts As Covid Sales Plummet With 90% Of Revenue Still To Come
Investor's Business Daily· 3 days agoBioNTech stock seesawed before closing in the green on Monday following a disappointing...
UPDATE 1-BioNTech says 90% of 2024 revenues will accrue at end of year
Reuters via Yahoo Finance· 4 days agoGermany's BioNTech , whose COVID-19 vaccine in partnership with Pfizer was widely used during the pandemic, said on Monday that almost all of its expected 2024 revenues would ...
BioNTech Target of Unusually Large Options Trading (NASDAQ:BNTX)
ETF DAILY NEWS· 2 days agoBioNTech SE (NASDAQ:BNTX – Get Free Report) was the recipient of some unusual options trading on Monday. BMO Capital Markets cut their price objective on BioNTech ...
BioNTech Revenue Falls Sharply on Reduced Covid Vaccine Sales
Barrons.com· 4 days agoFEATURE U.S.-listed shares of BioNTech were falling Monday after the German company that partnered...
BioNTech shares dip 2% on earnings and revenue miss By Investing.com
Investing.com· 4 days agoShares of BioNTech SE (NASDAQ:BNTX) fell 2.2% following the announcement of the first quarter...
AstraZeneca pulls its COVID-19 vaccine from Europe
Boston Herald· 11 hours agoThe pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator....